75 companies

Anthem Biosciences

Market Cap: ₹425.5b

Operates as technology-focused contract research, development, and manufacturing organization.

ANTHEM

₹757.60

7D

-5.4%

1Y

n/a

Basilea Pharmaceutica

Market Cap: CHF 591.7m

A Swiss commercial-stage biotech company focused on developing and commercializing treatments for severe bacterial and fungal infections.

BSLN

CHF 48.15

7D

-1.9%

1Y

5.6%

Neuren Pharmaceuticals

Market Cap: AU$2.6b

A biopharmaceutical company, develops drugs for the treatment of neurological disorders.

NEU

AU$20.65

7D

-3.5%

1Y

57.3%

Medpace Holdings

Market Cap: US$14.6b

Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.

MEDP

US$528.07

7D

5.4%

1Y

48.2%

Orion Oyj

Market Cap: €9.4b

Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.

ORNBV

€67.15

7D

-2.6%

1Y

41.0%

Abbott India

Market Cap: ₹633.4b

Operates as a pharmaceutical company in India.

500488

₹29,806.85

7D

-1.2%

1Y

2.1%

Xiamen Amoytop Biotech

Market Cap: CN¥31.6b

Engages in research, development, production, and sale of recombinant protein drugs in China.

688278

CN¥77.65

7D

-4.7%

1Y

-6.7%

ChemoMetec

Market Cap: DKK 11.7b

Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.

CHEMM

DKK 670.00

7D

-1.3%

1Y

52.3%

SK Biopharmaceuticals

Market Cap: ₩7.9t

A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.

A326030

₩101,000.00

7D

-2.8%

1Y

-18.0%

GlaxoSmithKline Pakistan

Market Cap: PK₨136.4b

Operates as a biopharma company in Pakistan.

GLAXO

PK₨428.32

7D

-0.4%

1Y

103.6%

Torrent Pharmaceuticals

Market Cap: ₹1.2t

Engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally.

500420

₹3,578.85

7D

1.2%

1Y

3.8%

Jamjoom Pharmaceuticals Factory

Market Cap: ر.س11.2b

Manufactures and markets pharmaceutical products in the Kingdom of Saudi Arabia and internationally.

4015

ر.س159.80

7D

2.4%

1Y

-5.4%

Blue Jet Healthcare

Market Cap: ₹113.3b

Engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products.

BLUEJET

₹653.30

7D

-3.6%

1Y

26.4%

Consun Pharmaceutical Group

Market Cap: HK$12.8b

Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.

1681

HK$15.07

7D

-8.6%

1Y

88.4%

Exelixis

Market Cap: US$10.6b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

EXEL

US$39.25

7D

2.9%

1Y

35.8%

Catalyst Pharmaceuticals

Market Cap: US$2.5b

A commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.

CPRX

US$20.55

7D

0.9%

1Y

-3.2%

Waters

Market Cap: US$19.9b

Provides analytical workflow solutions in Asia, the Americas, and Europe.

WAT

US$334.59

7D

1.1%

1Y

-4.0%

Lotus Pharmaceutical

Market Cap: NT$78.8b

Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.

1795

NT$299.50

7D

8.1%

1Y

15.6%

BioArctic

Market Cap: SEK 26.5b

Develops biological drugs for patients with central nervous system disorders in Sweden.

BIOA B

SEK 299.00

7D

2.7%

1Y

87.6%

Middle East Pharmaceutical Industries

Market Cap: ر.س2.7b

Engages in the research, development, manufacture, and marketing of generic medicines and pharmaceutical preparations in the Kingdom of Saudi Arabia and internationally.

4016

ر.س137.00

7D

3.6%

1Y

3.0%

Shanghai Allist Pharmaceuticals

Market Cap: CN¥46.8b

A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China.

688578

CN¥104.07

7D

-0.01%

1Y

89.6%

DHG Pharmaceutical

Market Cap: ₫13.3t

Engages in the manufacture and sale of pharmaceutical products in Vietnam.

DHG

₫101,400.00

7D

-0.8%

1Y

-5.0%

ACADIA Pharmaceuticals

Market Cap: US$3.5b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.

ACAD

US$20.89

7D

4.1%

1Y

36.5%

Harmony Biosciences Holdings

Market Cap: US$1.5b

A commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States.

HRMY

US$25.90

7D

-2.4%

1Y

-26.9%

Shandong Wit Dyne HealthLtd

Market Cap: CN¥7.5b

Engages in the pharmaceutical business in China.

000915

CN¥31.96

7D

-2.2%

1Y

4.0%

Incyte

Market Cap: US$17.0b

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

INCY

US$87.57

7D

4.5%

1Y

31.9%

Hunan Jiudian Pharmaceutical

Market Cap: CN¥8.3b

Researches, develops, produces, and sells pharmaceutical products in China and internationally.

300705

CN¥16.82

7D

-1.9%

1Y

-30.0%

WuXi AppTec

Market Cap: CN¥284.6b

An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally.

603259

CN¥96.60

7D

-7.8%

1Y

92.4%

Lupin

Market Cap: ₹885.6b

Operates as a pharmaceutical company in India, the United States, and internationally.

500257

₹1,938.85

7D

-1.1%

1Y

-10.9%

Genmab

Market Cap: DKK 129.0b

A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.

GMAB

DKK 2,095.00

7D

2.5%

1Y

34.0%

Gubra

Market Cap: DKK 6.6b

A biotech company, focuses on the pre-clinical contract research and peptide-based drug discovery within metabolic and fibrotic diseases in Europe, North America, and internationally.

GUBRA

DKK 405.20

7D

-6.0%

1Y

-5.3%

Tianjin Pharmaceutical Da Ren Tang Group

Market Cap: CN¥30.2b

Produces and sells traditional Chinese medicine, western medicine, and other products primarily in the People’s Republic of China.

600329

CN¥46.12

7D

5.3%

1Y

34.0%

HBM Holdings

Market Cap: HK$10.7b

A biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally.

2142

HK$12.79

7D

-9.4%

1Y

915.1%

NATCO Pharma

Market Cap: ₹148.0b

A pharmaceutical company, engages in the research and development, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally.

NATCOPHARM

₹826.20

7D

-2.3%

1Y

-40.9%

CytomX Therapeutics

Market Cap: US$540.9m

Operates as an oncology-focused biopharmaceutical company that focuses on developing novel conditionally activated biologics localized to the tumor microenvironment.

CTMX

US$3.20

7D

-4.8%

1Y

171.2%

Zealand Pharma

Market Cap: DKK 31.8b

A biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.

ZEAL

DKK 452.10

7D

-9.3%

1Y

-43.8%

Page 1 of 3